Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Scientists at University of Tubingen, Department of Dermatology discuss research in cancer vaccines
March 11th, 2008
New investigation results, 'Plasmid DNA- and messenger RNA-based anti-cancer vaccination,' are detailed in a study published in Immunology Letters. According to a study from Tubingen, Germany, "Tumor cells (over-) express specific antigens which allow them to be recognized and destroyed by the immune system. Triggering anti-tumor immunity in cancer patients by specific vaccination is foreseen as a safe and versatile method to control cancer." "As a source of antigen, whole tumor cells, nucleic acids, proteins or derived peptides have been used. This review focuses on the utilization of vaccines based on plasmid DNA (pDNA) and messenger RNA (mRNA) coding for tumor...
Source: Cancer Weekly (2008-03-11)
|
